Novasep teams up with Rohm and Haas
provide separation media, processes and systems for manufacturers
of biologic drugs.
The collaboration between the Novasep Process network and Rohm and Haas Advanced Biosciences division will provide a full spectrum of products and services, said the firms.
Novasep Process brings process development, modeling, and implementation of global processes, including batch and continuous chromatography, ion exchange, and membrane technologies to the alliance.
Meanwhile, Advanced Biosciences is a specialist in polymer chemistry and functional beads. It has the capacity to develop, manufacture and supply superior performance separation media from analytical to large scale quantities, which increase purity and yield and lower production costs.
The combined offering will provide bio-purification from laboratory to industrial scale, and will create new opportunities for both companies in the biopharmaceutical market. Groupe Novasep gains direct access to customized separation media while Advanced Biosciences gains access to advanced process development, including modeling and pilot scale capabilities.
"We believe that by working together and leveraging technologies and competencies, we can address needs of the biopharmaceutical market and serve a broader range of customers," said Roger-Marc Nicoud, president and CEO of Groupe Novasep.
"We will give more value to our customers and strengthen our mutual position in the marketplace," added Carol Eicher, Rohm and Haas vice president.
The companies said the alliance presents 'a promising pipeline' of new products as well as innovative and performing separation processes to address unmet needs in the biopharmaceutical market, such as eliminating downstream bottlenecks and increasing efficiency to meet the growing demand for biologics.